Diabetes Medicines Market Report – Research, Industry Analysis Reports and Market Demands

Global Diabetes Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Diabetes Medicines Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Oral
- 1.3.3 Injection
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Diabetes Medicines Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Retail Pharmacy
1.5 Global Diabetes Medicines Market Size & Forecast
- 1.5.1 Global Diabetes Medicines Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Diabetes Medicines Sales Quantity (2019-2030)
- 1.5.3 Global Diabetes Medicines Average Price (2019-2030)

2 Manufacturers Profiles

3 Competitive Environment: Diabetes Medicines by Manufacturer

3.1 Global Diabetes Medicines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Diabetes Medicines Revenue by Manufacturer (2019-2024)
3.3 Global Diabetes Medicines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Diabetes Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Diabetes Medicines Manufacturer Market Share in 2023
- 3.4.3 Top 6 Diabetes Medicines Manufacturer Market Share in 2023
3.5 Diabetes Medicines Market: Overall Company Footprint Analysis
- 3.5.1 Diabetes Medicines Market: Region Footprint
- 3.5.2 Diabetes Medicines Market: Company Product Type Footprint
- 3.5.3 Diabetes Medicines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Diabetes Medicines Market Size by Region
- 4.1.1 Global Diabetes Medicines Sales Quantity by Region (2019-2030)
- 4.1.2 Global Diabetes Medicines Consumption Value by Region (2019-2030)
- 4.1.3 Global Diabetes Medicines Average Price by Region (2019-2030)
4.2 North America Diabetes Medicines Consumption Value (2019-2030)
4.3 Europe Diabetes Medicines Consumption Value (2019-2030)
4.4 Asia-Pacific Diabetes Medicines Consumption Value (2019-2030)
4.5 South America Diabetes Medicines Consumption Value (2019-2030)
4.6 Middle East & Africa Diabetes Medicines Consumption Value (2019-2030)

5 Market Segment by Type

5.1 Global Diabetes Medicines Sales Quantity by Type (2019-2030)
5.2 Global Diabetes Medicines Consumption Value by Type (2019-2030)
5.3 Global Diabetes Medicines Average Price by Type (2019-2030)

6 Market Segment by Application

6.1 Global Diabetes Medicines Sales Quantity by Application (2019-2030)
6.2 Global Diabetes Medicines Consumption Value by Application (2019-2030)
6.3 Global Diabetes Medicines Average Price by Application (2019-2030)

7 North America

7.1 North America Diabetes Medicines Sales Quantity by Type (2019-2030)
7.2 North America Diabetes Medicines Sales Quantity by Application (2019-2030)
7.3 North America Diabetes Medicines Market Size by Country
- 7.3.1 North America Diabetes Medicines Sales Quantity by Country (2019-2030)
- 7.3.2 North America Diabetes Medicines Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

8.1 Europe Diabetes Medicines Sales Quantity by Type (2019-2030)
8.2 Europe Diabetes Medicines Sales Quantity by Application (2019-2030)
8.3 Europe Diabetes Medicines Market Size by Country
- 8.3.1 Europe Diabetes Medicines Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Diabetes Medicines Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

9.1 Asia-Pacific Diabetes Medicines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Diabetes Medicines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Diabetes Medicines Market Size by Region
- 9.3.1 Asia-Pacific Diabetes Medicines Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Diabetes Medicines Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

10.1 South America Diabetes Medicines Sales Quantity by Type (2019-2030)
10.2 South America Diabetes Medicines Sales Quantity by Application (2019-2030)
10.3 South America Diabetes Medicines Market Size by Country
- 10.3.1 South America Diabetes Medicines Sales Quantity by Country (2019-2030)
- 10.3.2 South America Diabetes Medicines Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

11.1 Middle East & Africa Diabetes Medicines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Diabetes Medicines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Diabetes Medicines Market Size by Country
- 11.3.1 Middle East & Africa Diabetes Medicines Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Diabetes Medicines Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

12.1 Diabetes Medicines Market Drivers
12.2 Diabetes Medicines Market Restraints
12.3 Diabetes Medicines Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Diabetes Medicines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Diabetes Medicines
13.3 Diabetes Medicines Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Diabetes Medicines Typical Distributors
14.3 Diabetes Medicines Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
According to our (Global Info Research) latest study, the global Diabetes Medicines market size was valued at US$ 100230 million in 2023 and is forecast to a readjusted size of USD 210010 million by 2030 with a CAGR of 11.0% during review period.
Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%.
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.
This report is a detailed and comprehensive analysis for global Diabetes Medicines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Diabetes Medicines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Medicines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Medicines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Medicines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetes Medicines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetes Medicines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Diabetes Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Retail Pharmacy
Major players covered
Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diabetes Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diabetes Medicines, with price, sales quantity, revenue, and global market share of Diabetes Medicines from 2019 to 2024.
Chapter 3, the Diabetes Medicines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetes Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Diabetes Medicines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diabetes Medicines.
Chapter 14 and 15, to describe Diabetes Medicines sales channel, distributors, customers, research findings and conclusion.

Buy now